HemaSphere
(Aug 2023)
P1253: REDUCED EXPRESSION OF THE CHEMOKINES CXCL2, CXCL3 AND CXCL8 PROVIDES A POTENTIAL MECHANISM PROMOTING IMMUNE EVASION FACILITATING AML RELAPSE FOLLOWING ALLOGENEIC HSCT
Sarah Charrot,
Jennifer Ball,
Findlay Copley,
James Aries,
Matthew Mee,
Symeon Theocharidis,
James Heward,
John Gribben,
Jeff Davies
Affiliations
Sarah Charrot
1 Barts Cancer Institute, United Kingdom
Jennifer Ball
1 Barts Cancer Institute, United Kingdom
Findlay Copley
1 Barts Cancer Institute, United Kingdom
James Aries
1 Barts Cancer Institute, United Kingdom
Matthew Mee
1 Barts Cancer Institute, United Kingdom
Symeon Theocharidis
1 Barts Cancer Institute, United Kingdom
James Heward
1 Barts Cancer Institute, United Kingdom
John Gribben
1 Barts Cancer Institute, United Kingdom
Jeff Davies
1 Barts Cancer Institute, United Kingdom
DOI
https://doi.org/10.1097/01.HS9.0000971900.04357.80
Journal volume & issue
Vol. 7
p.
e0435780
WeChat QR code
Close